Divi’s Laboratories reports 42% fall in Q1 net profit

24 Jul 2017 Evaluate

Divi’s Laboratories has reported results for first quarter ended June 30, 2017.

The company has reported 41.51% fall in its net profit at Rs 176.54 crore for the quarter under review as compared to Rs 301.81 crore for the same quarter in the previous year. Total revenue from operations of the company decreased by 17.67% at Rs 850.88 crore for Q1FY18 as compared Rs 1033.50 crore for the corresponding quarter previous year.

Divi’s Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

3918.75 6.85 (0.18%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.